Sanofi and Boehringer Ingelheim confirmed closing (in most markets) on 1 January 2017 of a $25bn transaction involving the exchange of Sanofi’s animal health business and Boehringer Ingelheim’s consumer healthcare business.
Bär & Karrer acted as Swiss legal adviser to Sanofi. The team included Ralph Malacrida, Micha Schilling (both M&A), Mani Reinert (competition), Markus Wang and Raffael Nusser (both IP).
Weil Gotshal & Manges acted as global lead counsel to Sanofi.
The post Sanofi and Boehringer swap businesses with advice from Bär & Karrer appeared first on The Lawyer | Legal News and Jobs | Advancing the business of law.